Mepha Pharma AG
Mepha Pharma AG is a Generics company based in Basel (Basel-Stadt) recorded by Swissmedic as the authorisation holder for 334 human medicines. That places it 2 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | Generics |
|---|---|
| City | Basel |
| Canton | Basel-Stadt |
| Authorisation holder | Yes |
| Medicines | 334 |
| Founded | 1949 |
| Employees | 201-1000 |
| Parent group | Teva Pharmaceutical Industries |
| Activity | Not available |
| Website | mepha.ch |
Medicines authorised in Switzerland
Mepha Pharma AG is recorded by Swissmedic as the authorisation holder for 334 human medicines. The table shows 48 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
48 of 334 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Abacavir-Lamivudin-Mepha 600 mg/300 mg | 67064 | A | J05AR02 | 2018-07-04 |
| Acimethin | 48799 | B | V03AB26 | 1988-09-19 |
| Acyclovir-Mepha 200 | 53668 | A | J05AB01 | 1997-02-25 |
| Agomelatin-Mepha 25 mg | 67502 | B | N06AX22 | 2020-10-15 |
| Alendron-Mepha 70 mg | 57768 | B | M05BA04 | 2007-06-07 |
| Alendronat-Mepha | 58839 | B | M05BA04 | 2009-01-13 |
| Alfuzosin-Mepha retard | 68138 | B | G04CA01 | 2020-10-15 |
| Allopurinol-Mepha 100 mg | 58129 | B | M04AA01 | 2009-01-08 |
| Ambrisentan-Mepha 5 mg | 67294 | B | C02KX02 | 2020-10-27 |
| Amiodaron-Mepha 100 mg | 55349 | B | C01BD01 | 2000-02-28 |
| Amisulprid-Mepha 200 | 59514 | B | N05AL05 | 2010-07-05 |
| Amisulprid-Mepha 400 | 59515 | B | N05AL05 | 2010-07-05 |
| Amlodipin-Mepha 5 | 56991 | B | C08CA01 | 2005-02-04 |
| Amlodipin-Valsartan-HCT-Mepha 5mg/160mg/12.5mg | 65890 | B | C09DX01 | 2016-11-02 |
| Amlodipin-Valsartan-Mepha Teva 5/80 mg | 65801 | B | C09DB01 | 2017-04-03 |
| Amorolfin-Mepha 5% | 65132 | B | D01AE16 | 2014-10-07 |
| Amoxi-Mepha 200 mg/4 mL | 49929 | A | J01CA04 | 1990-09-21 |
| Amoxi-Mepha 500 | 44911 | A | J01CA04 | 1983-04-26 |
| Apixaban-Mepha 2.5 mg | 69168 | B | B01AF02 | 2023-06-07 |
| Apixaban-Mepha Teva 2.5 mg | 70006 | B | B01AF02 | 2025-06-13 |
| Apremilast-Mepha 10 mg | 69498 | B | L04AA32 | 2025-07-22 |
| Aripiprazol Actavis 5 mg | 65428 | B | - | 2015-12-16 |
| Aripiprazol-Mepha 1mg/ml | 66977 | B | N05AX12 | 2018-10-04 |
| Aripiprazol-Mepha 5 mg | 65471 | B | N05AX12 | 2015-06-30 |
| Aripiprazol-Mepha oro 10 mg | 65478 | B | N05AX12 | 2015-06-30 |
| ASS Cardio-Mepha | 62784 | B | B01AC06 | 2013-11-19 |
| Atazanavir-Mepha 150 mg | 66339 | A | J05AE08 | 2017-09-19 |
| Atenolol-Mepha 50 | 50075 | B | C07AB03 | 1989-09-28 |
| Atomoxetin-Mepha 10 mg | 67588 | A | N06BA09 | 2020-01-16 |
| Atorvastatin-Mepha 10 mg | 69314 | B | C10AA05 | 2024-08-21 |
| Atorvastatin-Mepha Teva 10 mg | 61364 | B | C10AA05 | 2011-07-05 |
| Atorvastatin-Teva 10 mg | 61322 | B | C10AA05 | 2011-10-13 |
| Atovaquon-Proguanil-Mepha 250 / 100 | 67872 | A | P01BB51 | 2021-04-29 |
| Aviral | 55060 | D | D06BB03 | 2000-09-22 |
| Azelastin-Fluticason-Mepha | 68730 | B | R01AD58 | 2023-05-11 |
| Azithromycin-Mepha 200 | 58081 | A | J01FA10 | 2007-07-25 |
| Azithromycin-Mepha 250 mg | 67761 | A | J01FA10 | 2021-01-29 |
| Betahistin-Mepha 16 | 58124 | B | N07CA01 | 2007-10-29 |
| Betahistin-Mepha Teva 16 mg | 68912 | B | N07CA01 | 2023-08-04 |
| Bilastin-Mepha 20 mg | 68002 | D | R06AX29 | 2021-11-01 |
| Bilastin-Mepha Allergie lingual 20 mg | 69558 | D | R06AX29 | 2025-03-16 |
| Bimatoprost-Mepha Plus | 66976 | B | S01ED51 | 2018-10-03 |
| Bisoprolol-Mepha 2.5 mg | 63190 | B | C07AB07 | 2013-05-23 |
| Bosentan-Mepha 62.5 mg | 65991 | B | C02KX01 | 2017-03-21 |
| Budesonid-Mepha | 68470 | B | A07EA06 | 2022-07-08 |
| Buprenorphin-Mepha 0.4 mg | 65188 | A+ | N07BC01 | 2014-12-12 |
| Buprenorphin-Mepha 35ug/h | 65809 | A+ | N02AE01 | 2015-05-19 |
| Calcipotriol-Betamethason-Mepha | 65269 | B | D05AX52 | 2015-10-15 |
Frequently asked questions
How many medicines does Mepha Pharma AG have authorised in Switzerland?
Mepha Pharma AG is recorded by Swissmedic as the authorisation holder for 334 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Mepha Pharma AG based?
The Swiss location recorded for Mepha Pharma AG is Basel, Basel-Stadt.
Is Mepha Pharma AG a Swissmedic authorisation holder?
Yes. Mepha Pharma AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.